GENinCode (LON:GENI) Stock Price Up 12.1% – Time to Buy?

GENinCode Plc (LON:GENI) was up 12.1% on Tuesday . The company traded as high as GBX 1.25 and last traded at GBX 1.21. Approximately 11,170,745 shares changed hands during trading, an increase of 118% from the average daily volume of 5,121,070 shares. The stock had previously closed at GBX 1.08.

GENinCode Stock Performance

The stock has a market capitalization of £3.30 million, a PE ratio of -0.49 and a beta of 0.66. The firm’s fifty day moving average is GBX 1.68 and its 200-day moving average is GBX 2.32. The company has a current ratio of 2.60, a quick ratio of 15.89 and a debt-to-equity ratio of 9.28.

GENinCode Company Profile

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.